The Merck Propecia® (Alleged Sexual Side Effects) MDL Is Slowly Gathering Steam

Thanks to an anonymous commenter on the backup blog, we will offer this long-overdue update on the federal Merck Propecia® litigation, this morning:

Yes, you are right, Anon. — the Magistrate is holding an adjourned status conference on November 20, in MDL 12-2331, in the Eastern District of New York:

This is the alleged sexual side effects (primarily erectile dysfunction) MDL. We will report as a new post, any material development, but discovery is just getting underway here — so it may be a bit before anything big shakes loose. And I’d not expect settlement talks will get anywhere, in earnest, until much more discovery has been completed.

. . . .ORDER granting (No. 138 in 1:12-md-02331-JG-VVP) letter application to adjourn. The 10/16/13 conference is rescheduled for Wednesday, November 20, 2013 at 2:00 p.m. Ordered by Magistrate Judge Viktor V. Pohorelsky on 10/3/2013. Associated Cases: 1:12-md-02331-JG-VVP et al. . . .

[My backgrounder, here.] Thanks for asking, and Namaste!


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s